Contract Services
Redbud raises $10M in series A round as CRO focusing on science-driven clinical development
Redbud Medicine is a next-generation clinical CRO focusing on science-based clinical development services. The company offers full-service development from...
September 13, 2022 | News
WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility
WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new sterile lipid nanoparticle (LNP) formulation development and manufacturing faci...
September 12, 2022 | News
Catalent Expands Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
The investment will increase the site’s footprint by nearly 20% to 31,000 square feet, and allow the installation of 35 new freezers for ultra-low ...
September 07, 2022 | News
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5In addition, the GlobalData...
September 05, 2022 | News
WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility
The site's clinical manufacturing operations have an initial capacity of 4,000L and will grow to 6,000L, utilizing only single-use technology, adding to th...
September 01, 2022 | News
Porton Advanced and Royaltech Announce Strategic Collaboration to Accelerate the Development of Bacterial Drugs and mRNA Drugs
This strategic collaboration will further integrate the resources and capabilities of both parties, jointly promote the establishment of microbial vec...
August 30, 2022 | News
Liminal BioSciences Announces Termination of Legacy CDMO Contract
Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a development-stage biopharmaceutical company, announced today that,...
August 26, 2022 | News
Catalent to Acquire Metrics Contract Services for $475 Million
Catalent, Inc. (NYSE: CTLT), the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and sup...
August 23, 2022 | News
Selecxine, a partner of GenScript ProBio, announces FDA clearance of its IND application for innovative antibody drug program (SLC-3010)
In December 2019, GenScript ProBio announced the strategic collaboration with Selecxine for an innovative antibody drug program. The project (SLC-3010...
August 23, 2022 | News
WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility
First announced in June 2021, this site will be WuXi STA's second facility in the United States, offering expanded capacity and greater flexibili...
August 17, 2022 | News
Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform
Reduces process development time by an estimated 40 percent Enables biopharmaceutical companies to increase the speed to clinical manufacturing ...
August 10, 2022 | News
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15
-Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vacc...
August 09, 2022 | News
LG Chem Enters Final Stage of Clinical Development for New Gout Drug
In global Phase 3 clinical trial, Tigulixostat will be evaluated in 350 adult gout patients with hyperuricemia for safety and efficacy at Month 6 of treatm...
August 04, 2022 | News
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine
GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities Technology transfer and scale-up from lab benc...
August 02, 2022 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
